Myeloid-derived Suppressor Cells and Multiple Sclerosis.

Area of Science:

• Immunology
• Neuroimmunology
• Cellular Biology

Background:

• Myeloid-Derived Suppressor Cells (MDSCs) are critical regulators of immune responses and homeostasis.
• MDSCs comprise granulocytic (G-MDSCs) and monocytic (M-MDSCs) subsets with distinct properties.
• Recent focus on innate immunity in Multiple Sclerosis (MS) highlights the relevance of MDSCs.

Purpose of the Study:

• To review the characteristics of MDSCs in Multiple Sclerosis (MS) and its preclinical models.
• To discuss the dysregulation of MDSC immunosuppressive functions in MS pathogenesis.
• To explore the therapeutic potential of targeting MDSCs for MS treatment.

Main Methods:

• Review of recent scientific literature on MDSCs in MS and preclinical models.
• Analysis of data concerning MDSC subsets, functions, and their role in disease progression.
• Examination of various strategies for modulating MDSCs, including pharmacological and adoptive transfer approaches.

Main Results:

• MDSC immunosuppressive functions are often dysregulated in MS, potentially exacerbating autoimmune responses.
• Targeting MDSCs is identified as a promising therapeutic avenue for MS.
• Various strategies exist for modulating MDSCs, but their precise impact on MS remains under investigation.

Conclusions:

• MDSCs play a pivotal role in the regulation of Multiple Sclerosis.
• Modulating MDSCs presents a potential therapeutic strategy for MS, aiming to restore immune tolerance.
• Further research is needed to fully elucidate the therapeutic mechanisms and efficacy of MDSC-targeted therapies in MS.